Conflicts of Interest

By Jordan Paradise
In Conflicts of Interest
Dec 11th, 2014
0 Comments
By Jordan Paradise This week, the New York Times reported that ophthalmologists who were paid to promote Genentech’s drug Lucentis (ranibizumab) were among the top billers of the drug to federal programs, exceeding the prescribing amounts of more than 75% of their peers.  Lucentis, approved in 2006 by the Food and Drug Administration (FDA), is indicated […]...
By Kathleen M. Boozang
In Conflicts of Interest
Jul 31st, 2012
0 Comments
When we think about health care reform, we need to remember that we have been attempting reforms through many avenues of myriad parts of our health system.  The IRS revised Form 990 and schedule H in anticipation of the ACA; critics of conflicts of interest have been working on multiple fronts simultaneously.  One of the […]...
By Kate Greenwood
In Conflicts of Interest
Aug 24th, 2011
0 Comments
Yesterday, at long last, the National Institutes of Health released the final revisions to its regulations governing financial conflicts of interest on the part of applicants for federal research funds.  And there is good news.  The rule’s sunshine provisions have not, as was feared, been “gutted.”  Grant recipients will have to make their investigato...
By Kate Greenwood
In Conflicts of Interest
May 25th, 2011
0 Comments
On Tuesday, the Food and Drug Administration released a draft guidance on financial disclosure by clinical investigators, targeted at the investigators themselves, at drug and device companies and others who sponsor clinical trials, and at the agency staff who review the disclosures.  In the draft guidance, which updates an earlier one, the FDA briefly reviews [&hellip...
By Kathleen M. Boozang
In Conflicts of Interest
Feb 10th, 2011
0 Comments
Seton Hall University School of Law’s Center for Health & Pharmaceutical Law & Policy has issued a White Paper, “The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research,” in which the Center agrees that public policy should encourage researchers and institutions to make information about their financial r...